@misc{oai:repo.qst.go.jp:00064525,
 author = {Imai, Reiko and Kamada, Tadashi and Tsuji, Hiroshi and Maruyama, Katsuya and Matsumoto, Keiji and Tsujii, Hirohiko and 今井 礼子 and 鎌田 正 and 辻 比呂志 and 丸山 克也 and 松本 圭司 and 辻井 博彦},
 month = {Feb},
 note = {A clinical trial was first initiated in 1996 to evaluate the safety and efficacy of carbon ion radiotherapy for bone and soft tissue sarcomas not suitable for surgery. 
As of February 2011, a total of 800 patients were enrolled in the clinical trials. Through a dose escalation trial and a subsequent fixed dose trial, it was revealed that carbon ion radiotherapy provided definite local control and offered a survival advantage without unacceptable morbidity for patients with bone and soft tissue cancers that were either difficult or impossible to cure using other modalities., NIRS-KFSHRC Joint Symposium on Carbon Ion Radiotherapy and Radiation Emergency Medicine},
 title = {Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas},
 year = {2012}
}